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Voiding Dysfunction
Preventive Effect of Tamsulosin on Postoperative Urinary 
Retention
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Urology, Nephrology & Kidney Transplant Research Center, Department of Urology, Imam Medical Center, Urmia University of Medical 
Sciences, Urmia, Iran
Purpose: To investigate the prophylactic effect of Tamsulosin, a super-selective al-
pha-1a adrenergic blocking agent, on the development of urinary retention in men un-
dergoing elective inguinal herniorrhaphy.
Materials and Methods: From May 2010 through November 2011, a total of 80 males 
who underwent elective inguinal herniorrhaphy in a university hospital were included 
in this study. Patients were randomly assigned to one of two groups. In group one 
(control), the patients were given two doses of placebo orally, 6 hours before surgery 
and 6 to 12 hours after surgery. Patients in group two were given 0.4 mg of Tamsulosin 
orally in the same manner as the placebo. All patients were closely followed for 24 hours 
post-operatively, and any voiding difficulties or urinary retention was recorded.
Results: There were 40 patients in group one (control group) and 40 patients in group 
two (Tamsulosin group). The patients’ mean age was 64 years. In group one, 6 patients 
and in group two, 1 patient required catheterization. Thus, 15% of patients in group 
I and 2.5% of patients in group II had urinary retention. The difference in the require-
ment for catheterization was statistically significant (p=0.04). The technique of her-
niorrhaphy, the side of the body in which the hernia was located, the type of anesthesia, 
the duration of the surgery, and the severity of pre-operative urinary symptoms had 
no significant effect on the incidence of urinary retention.
Conclusions: The use of perioperative Tamsulosin represents an effective strategy to 
reduce the risk of post-operative urinary retention following inguinal herniorrhaphy.
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INTRODUCTION
Postoperative urinary retention (POUR) is a common and 
potentially serious morbidity with a reported incidence of 
3 to 25% [1]. POUR has generally been defined as the inabil-
ity to pass any urine in the presence of a palpable or percus-
sible bladder after surgery, but the definition varies 
widely. 
POUR occurs in patients of both sexes and all age groups 
and after all types of surgical procedures. It occurs more 
frequently after lower urinary tract, perineal, gynecologic, 
and anorectal surgeries [1].
Both the health and financial costs of retention are con-
siderable, because it can cause urinary tract infections and 
necessitate catheterization, which can in turn result in ure-
thral strictures, prolonged hospital stays, and additional 
operations. Because of the necessity to seek immediate 
medical attention in order to relieve the severe discomfort, 
renal insufficiency is not often a complicating factor.
In several clinical studies, alpha-adrenergic blocking 
agents have been shown to have prophylactic and ther-
apeutic potential on POUR [2,3]. The alpha-1 receptor an-
tagonist acts by reducing tone in the bladder outlet, thereby 
decreasing outflow resistance and facilitating micturition.Korean J Urol 2012;53:419-423
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The aim of this randomized, prospective study was to in-
vestigate the prophylactic effect of tamsulosin, a super-se-
lective alpha-1a adrenergic blocking agent, on the develop-
ment of urinary retention in men undergoing elective in-
guinal herniorrhaphy.
MATERIALS AND METHODS
From May 2010 through November 2011, a total of 80 males 
who underwent elective inguinal herniorrhaphy in a uni-
versity hospital were included in this study. Female pa-
tients were not studied because of the small sample size.
The criteria for exclusion were as follows: active urinary 
tract infection, recurrent or bilateral hernia, age younger 
than 50 years, cardiopulmonary or other significant sys-
temic diseases, previous neurological disease, medications 
that could affect voiding function such as cholinergic drugs, 
previous urological surgery, previous urological disease 
such as urethral stricture or bladder or prostatic cancer, 
serum creatinine greater than 1.6 mg/dl, urinary incon-
tinency, and those with an indwelling Foley catheter.
All patients had a complete physical examination pre-
operatively, electrocardiogram, chest X-ray, and baseline 
blood analysis and urinalysis. In addition, all underwent 
preoperative ultrasonographic investigation (measure-
ment of residual urine and prostatic volume). Residual 
urine volume was measured just before the operation.
After informed consent was obtained from the patients, 
they were randomly assigned to one of two groups by the 
selection of an envelope in the preoperative holding area. 
In group one (control), the patients were given two doses 
of placebo orally, 6 hours before surgery and 6 to 12 hours 
after surgery. Patients in group two were given 0.4 mg of 
tamsulosin orally in the same manner as the placebo.
In all cases, administration of lactated Ringer’s solution 
(1.5 ml/kg/h) was begun in the operating room before the 
anesthetic was given and was continued postoperatively 
during the NPO period (for 4 to 6 hours).
Surgery was performed after the administration of ei-
ther a general endotracheal anesthetic agent (halothane) 
or a short-acting spinal anesthetic (5% lidocaine). The at-
tending anesthesiologist chose the type of anesthetic with-
out consulting the surgeon. 
The hernia repairs were done by use of either the Bassini 
procedure or McWay.
Postoperatively, the patients were initially given either 
pentazocine or morphine and then diclofenac suppository 
for pain control. The dosage of analgesia administered was 
adjusted until the patients reported zero to mild pain scores 
on a visual analogue scale.
All patients were closely followed for 24 hours post-
operatively, and any voiding difficulties or urinary re-
tention was recorded. 
Urinary retention was diagnosed when a patient had a 
palpable mass in the suprapubic area, felt discomfort, and 
failed to pass urine within 24 hours after the operation de-
spite a sufficient fluid intake and when conservative efforts 
such as warming the suprapubic region and encouraging 
the patient to stand up and walk were unsuccessful and 
bladder catheterization seemed inevitable.
Statistical analysis was accomplished by use of the 
chi-square test and Fisher’s exact test with a p-value of less 
than 0.05 considered significant.
RESULTS
There were 40 patients in group one (control group) and 40 
patients in group two (tamsulosin group). Fifty-five her-
nias were right-sided and 25 were left-sided. The type of 
repair performed was modified Bassini in 70 patients and 
Cooper ligament repair (McWay) in 10 patients. Six pa-
tients in group one and 4 in group two had diabetes 
mellitus. The characteristics of the patients are listed in 
Table 1.
No statistically significant differences were found be-
tween the two groups in terms of age (p=0.18), severity of 
preoperative urinary symptoms (p=0.3), post-voiding re-
sidual urine volume (p=0.6), type of anesthesia (p=0.7), or 
duration of surgery (p=0.7). The average nonsteroidal an-
ti-inflammatory drug use in the two groups was similar 
(200 mg diclofenac suppository).
In group one, 6 patients required catheterization with a 
mean urine volume of 800 ml at catheterization. In group 
two, 1 patient required catheterization with a 600-ml mean 
urine volume. Thus, 15% of patients in group 1 and 2.5% 
of patients in group 2 had urinary retention. 
The difference in the requirement for catheterization 
was statistically significant (p=0.04). 
Too few patients had indirect inguinal hernia, thus pre-
cluding meaningful evaluation of the type of hernia.
The technique of herniorrhaphy (p=0.4), the side of the 
body in which the hernia was located (p=0.3), the type of 
anesthesia (p=0.2), and the duration of the surgery (p=0.1) 
had no significant effect on the incidence of urinary re-
tention and the necessity for catheterization (data not 
shown). Also, there was no statistically significant differ-
ence between the incidence of urinary retention and the se-
verity of pre-operative urinary symptoms (p=0.4).
No complications or side effects of therapy were encoun-
tered during the treatment with tamsulosin or placebo.
DISCUSSION
Urinary retention is a common complication after any sur-
gical procedure. It occurs more frequently after lower uri-
nary tract, perineal, gynecologic, and anorectal surgeries. 
The incidence of urinary retention after herniorrhaphy 
ranges from 0.2 to 30% [2]. The widely varying reported in-
cidence of POUR reflects differences in patient character-
istics, the lack of uniform defining criteria, and the multi-
factorial etiology of POUR, including age, gender, in-
adequate perioperative fluids, type of anesthesia, and type 
of surgery [4].
Urinary retention produces discomfort and it can lead to Korean J Urol 2012;53:419-423
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TABLE 1. Patient characteristics and operative parameters
Baseline characteristic
Group 1 
(placebo)
Group 2 
(tamsulosin)
p-value
No. of patients
Age (yr)
     Mean
     Range
Hernia side
     Right
     Left
Hernia type
     Direct
     Indirect
Technique of repair
     Bassini
     McWay
Pre-operative urinary 
symptoms
a
     No
     Mild
     Moderate
     Severe
Duration of surgery (h)
     ＜1 
     ＞1 
Anesthesia
     General
     Spinal
PVR before surgery (ml)
     ＜50 
     ＞50
Prostate volume (ml)
     Mean
     Range
40
   63.3
51-83
25 (62.5)
15 (37.5)
38 (95.0)
2 (5.0)
37 (92.5)
3 (7.5)
13 (32.5)
22 (55)
  5 (12.5)
0 (0)
34 (85.0)
  6 (15.0)
  7 (17.5)
33 (82.5)
29 (72.5)
11 (26.5)
42
27-99
40
   66.2
52-80
 30 (75.0)
 10 (25.0)
40 (100)
0 (0)
 33 (82.5)
   7 (17.5)
   8 (20.0)
 24 (60.0)
   8 (20.0)
0 (0)
 33 (82.5)
   7 (17.5)
   8 (20.0)
 32 (80.0)
 31 (77.5)
   9 (22.5)
45
30-90
  0.18
0.1
0.2
0.3
0.7
0.7
0.6
0.3
Values are presented as number (%).
AUA, American Urological Association; PVR, post-void urinary 
retention.
a:According to AUA symptom score.
urethral injury and urinary tract infection following 
catheterization. In addition, with increasing financial con-
straints and the trend toward early discharge, avoidance 
of this perioperative complication is particularly impor-
tant. Although most patients may recover from POUR with 
a trial without catheter (TWOC) after a few days of cathe-
terization, some patients with POUR can have persistent 
urinary retention after failure of TWOC and this prolongs 
or complicates the postoperative recovery phase. There-
fore, efforts should be made to prevent POUR, especially 
in men at high risk for the condition.
Many factors contribute to the development of POUR. 
These include the direct effects of anesthetic agents on the 
bladder, traumatic instrumentation, pelvic dissection, 
overzealous intravenous hydration resulting in bladder 
distension, diminished awareness of bladder sensation, in-
creased outlet resistance, immobilization after the proce-
dure, postoperative pain (nociceptive inhibitory reflex), 
use of narcotics for analgesia, and patient age and sex [5]. 
Toyonaga et al. [6] showed that female sex, preoperative 
urinary symptoms, diabetes mellitus, large amounts of in-
travenous fluid administered perioperatively, and post-
operative pain are independent risk factors for urinary re-
tention in selected cases of anorectal surgery such as hem-
orrhoidectomy and fistulectomy.
Petros et al. [5] retrospectively reviewed 295 inguinal 
herniorrhaphies in men. They found age less than 53 years, 
spinal anesthesia, and perioperative fluids less than 1,200 
ml all significantly reduced the incidence of POUR.
The contractility of the detrusor decreases with advanc-
ing age. Accordingly, in light of previous studies, it was gen-
erally assumed that POUR increases with age, with the 
risk increasing by 2.4 to 2.8 times in patients over 50 years 
of age [7]. Age is an independent factor predicting success-
ful TWOC for POUR and patients older than 70 years are 
at a 1.8 times higher risk of failure of TWOC than are those 
younger than 70 years [8].
Controversy exists about the impact of gender on the de-
velopment of POUR. Some studies have shown that gender 
is not significantly correlated with the development of 
POUR [5], whereas other studies reported a higher in-
cidence of POUR in men than in women [9].
Many different methods have been tried to prevent this 
complication, including the use of parasympathomimetic 
agents, use of α-adrenergic blockers, use of anxiolytic 
agents, restriction of perioperative fluid intake, avoidance 
of anal packing, sitz baths, use of local anesthesia, use of 
short-acting anesthesia, and outpatient surgery. 
Some precautions, such as limitation of fluid intake, ear-
ly mobilization, warm compress to the suprapubic area, 
and the use of short-acting local or spinal anesthesia have 
been reported to prevent this complication.
The overwhelming majority of inguinal herniorrhaphies 
are performed as elective outpatient procedures without 
intra-operative catheterization. Therefore, limiting the 
perioperative volume of fluids and controlling pain are rea-
sonable measures to reduce POUR [10].
In a randomized prospective study of perioperative fluid 
restriction in anorectal surgery, Bailey and Ferguson were 
able to reduce urinary retention from 14.9 to 3.5% [11].
The avoidance of acute bladder overdistention in order 
to prevent POUR is supported by the experimental ob-
servation of a reduced bladder response to sacral neural 
stimulation during overdistention (＞80% reduction) as 
well as after overdistention (19% reduction) [12].
The type of anesthesia during surgery is another im-
portant factor in the development of POUR. In a group of 
880 patients undergoing inguinal herniorrhaphy using lo-
cal anesthesia, Finley et al. [13] noticed that the incidence 
of POUR was 0.2%. During the same period, a similar group 
of 200 patients had their hernias repaired with the use of 
general or spinal anesthesia. The incidence of POUR in 
that group was 13%. The authors contended that the use 
of local anesthesia in inguinal hernia repair almost elimi-
nates POUR.Korean J Urol 2012;53:419-423
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Jensen et al. [14] recently reported a Medline-based 
search intended to determine the incidence of POUR fol-
lowing herniorrhaphy. The incidences of POUR following 
inguinal herniorrhaphies performed under local anes-
thesia, regional anesthesia, and general anesthesia were 
0.37%, 2.4%, and 3.0%, respectively. The investigators con-
cluded that the type of anesthesia significantly influenced 
the risk of POUR. 
An alternative explanation for the low risk of POUR fol-
lowing herniorrhaphies performed under local anesthesia 
is superior pain control [15]. 
Efforts toward the pharmacological prevention and 
treatment of POUR have focused on increasing detrusor 
muscle activity or decreasing the opening pressure of the 
internal sphincter at the bladder neck. 
It is well documented that adrenergic receptors are pres-
ent throughout the bladder. Beta-adrenergic receptors are 
predominantly in the body and dome, and alpha-adrener-
gic receptors are in the base and neck of the bladder.
In the acute postoperative setting, sympathetic nerve 
discharge causes catecholamine release and α-adrener-
gic-mediated contraction of the bladder neck, resulting in 
functional obstruction of the bladder outlet.
Administration of sympathomimetic and anticholiner-
gic agents (for example, phenylephrine and atropine) dur-
ing anesthesia can inhibit contraction of the detrusor mus-
cle in the bladder. This relaxes the bladder and decreases 
the urge to void and the recognition that the bladder is full.
The pain in the inguinal area can stimulate the α-re-
ceptors in the bladder neck and proximal urethra, thereby 
increasing urethral resistance and bladder outlet tone. The 
end result is that attempts to void encounter increased out-
put resistance [16].
In a review article published by Buckley and Lapitan in 
2010 to find the best drug for the treatment of POUR in 
adults, they concluded that no statistically significant as-
sociations were reported between successful treatment or 
any other outcome and cholinergic agents, alpha-blockers, 
and sedatives as monotherapies. A statistically significant 
association between intravesically administered prosta-
glandin and successful voiding was detected (risk ratio, 
3.07). A statistically significant association was detected 
between cholinergic agents combined with sedative and an 
improved likelihood of spontaneous voiding compared with 
placebo (risk ratio, 1.39) [17].
Bethanechol (a parasympathomimetic agent) acts pri-
marily on the postganglionic effector cells, with a relatively 
selective muscarinic action on the smooth muscle of the 
bladder. Thus, bethanechol increases the intravesical 
pressure but produces no relaxation in the bladder outlet. 
Indeed, bethanechol has been shown to be virtually useless 
in humans and to do no more than increase bladder dis-
comfort and distress. Accordingly, bethanechol cannot be 
recommended as the drug of choice in the management of 
POUR [18].
α-Adrenergic blockade with phenoxybenzamine histor-
ically has seemed effective prophylactically in decreasing 
the incidence of postoperative retention. Velanovich per-
formed a meta-analysis on the use of phenoxybenzamine 
and concluded that this agent reduced the occurrence by 
29.1% [14].
Goldman et al. [2] performed a randomized, placebo-con-
trolled trial to determine the role of alpha-blockers in re-
ducing the risk of POUR after hernioplasty. The study in-
cluded 102 men older than 60 years who were randomly as-
signed to receive phenoxybenzamine or a control. POUR 
developed in 26% of men in the control group and 0% of men 
who received phenoxybenzamine.
Prazosin, a selective alpha 1-adrenoceptor antagonist, 
produces clinical effects similar to those of phenoxybenz-
amine with less significant side effects. Prazosin has little 
selectivity for pre-synaptic alpha-2 adrenergic receptors 
but has marked selectivity for post-synaptic (alpha-1) 
adrenergic receptors. Gonullu et al. [3] demonstrated that 
the incidence of urinary retention after herniorrhaphy was 
25% in the placebo group, of whom 13.8% required 
catheterization. By contrast, 10.8% in the prazosin group 
developed urinary retention, of whom 3.5% required 
catheterization.
Tamsulosin is a superselective adrenoceptor antagonist 
(alpha-1a). Its preventive effect has not been previously 
studied in reducing the risk of POUR after herniorrhaphy. 
Patel et al. [19] investigated the potential efficacy of al-
pha-blockers for facilitating early removal of the urinary 
catheter following radical prostatectomy. A consecutive 
group of 250 men undergoing radical prostatectomy re-
ceived tamsulosin, 0.4 mg, 3 days before a cystography 
planned for postoperative day 8. Tamsulosin was ad-
ministered for an additional 4 days following the catheter 
removal. The incidence of POUR in the men who received 
tamsulosin was only 2.6% compared with 10% in control 
group.
Djavan et al. [20] reported a randomized study evaluat-
ing neoadjuvant and adjuvant alpha-blockade as a strat-
egy to decrease the risk of acute urinary retention following 
transurethral microwave thermotherapy (TUMT). In that 
study, 41 men with benign prostatic hyperplasia under-
went TUMT with neoadjuvant and adjuvant tamsulosin 
therapy (0.4 mg daily) and 40 men underwent TUMT alone. 
Urinary retention was observed in 12% of the TUMT-alone 
group and 2% of the tamsulosin-treated group. The use of 
neoadjuvant and adjuvant tamsulosin represents an effec-
tive strategy to reduce the risk of catheter dependency fol-
lowing TUMT and provides immediate symptom relief.
In the present study, 1 of 40 patients (2.5%) in the tamsu-
losin group developed urinary retention. In the placebo 
group, 6 of 40 patients (15%) had urinary retention and re-
quired catheterization. The incidence of acute urinary re-
tention was significantly greater in men who did not re-
ceive tamsulosin before and after surgery.
The incidence of urinary retention showed no statisti-
cally significant difference when we considered the techni-
que of herniorrhaphy, the side of the body in which the her-
nia was located, the type of anesthesia, or the duration of Korean J Urol 2012;53:419-423
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the surgery. The difference was also insignificant when the 
severity of preoperative urinary symptoms was compared 
between the two groups. Therefore, the use of tamsulosin 
can be recommended in adult male patients over 50 years 
of age who undergo inguinal hernia repair, regardless of 
their baseline characteristics.  
The current study is the only prospective evaluation of 
tamsulosin as a means of avoiding urinary retention after 
inguinal herniorrhaphy. This protocol resulted in the re-
duction of urinary retention from 15% in the controls to 
2.5% in the treatment group.
CONCLUSIONS
To the best of our knowledge, the effect of prophylactic tam-
sulosin has not been investigated in inguinal hernia 
operations. Our data suggest that tamsulosin significantly 
reduces the risk of acute urinary retention after surgery. 
Therefore, we recommend administering a perioperative 
course of tamsulosin therapy when performing inguinal 
herniorrhaphy.
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